|
Nov 7
|
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
Q3 2023 Coherus BioSciences Inc Earnings Call
|
|
Nov 6
|
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
|
|
Nov 3
|
Coherus Presents Data from Next-generation Immuno-oncology Programs at 38th Annual Meeting of Society for Immunotherapy of Cancer (SITC)
|
|
Nov 3
|
Coherus BioSciences to Participate at Upcoming November Investor Conferences
|
|
Sep 8
|
Coherus Completes Surface Oncology Acquisition
|
|
Sep 8
|
Why Coherus BioSciences Stock Was Plunging This Week
|